Safety and Effectiveness of Ledipasvir and Sofosbuvir, With or Without Ribavirin, in Treatment-Experienced Patients with Genotype 1 Hepatitis C Virus Infection and Cirrhosis

BACKGROUND & AIMS: We aimed to evaluate the safety and effectiveness of 12 or 24 weeks treatment with ledipasvir and sofosbuvir, with or without ribavirin, in treatment-experienced patients with hepatitis C virus (HCV) genotype 1 infection and cirrhosis in routine clinical practice. Patients wer...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Clin Gastroenterol Hepatol
Huvudupphovsmän: Lim, Joseph K., Liapakis, Ann Marie, Shiffman, Mitchell L., Lok, Anna S., Zeuzem, Stefan, Terrault, Norah A., Park, James S., Landis, Charles S., Hassan, Mohamed, Gallant, Joel, Kuo, Alexander, Pockros, Paul J., Vainorius, Monika, Akushevich, Lucy, Michael, Larry, Fried, Michael W., Nelson, David R., Ben-Ari, Ziv
Materialtyp: Artigo
Språk:Inglês
Publicerad: 2018
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC6034985/
https://ncbi.nlm.nih.gov/pubmed/29306043
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cgh.2017.12.037
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk